Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity
Neuron · 2023-04 · 111 (8) · 1282-1300.e8
DOI: 10.1016/j.neuron.2023.01.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2023-04. Verfasst von Evan C Rosenberg und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience & Physiology and Neuroscience Institute, NYU Langone Medical Center, 435 E 30th St, New York, NY 10016, USA. Hauptthemen laut MEDLINE: Cannabidiol. Die Arbeit wurde bisher 107-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience & Physiology and Neuroscience Institute, NYU Langone Medical Center, 435 E 30th St, New York, NY 10016, USA.
- School of Chemistry, Food and Nutritional Sciences, and Pharmacy, University of Reading, Hopkins Life Science Building, Whiteknights, Reading, Berks RG6 6AP, UK; GW Research Ltd, Histon, Cambridge, UK.
- Departments of Child and Adolescent Psychiatry, Neuroscience & Physiology, and Psychiatry, NYU Langone Medical Center, 435 E 30th St, New York, NY 10016, USA; Center for Dementia Research, Nathan Kline Institute for Psy…
- Aston Neuroscience Institute, School of Life and Health Sciences, Aston University, Birmingham, UK.
- School of Chemistry, Food and Nutritional Sciences, and Pharmacy, University of Reading, Hopkins Life Science Building, Whiteknights, Reading, Berks RG6 6AP, UK.
- Department of Advanced Research Technologies, NYU Langone Medical Center, 435 E 30th St, New York, NY 10016, USA.
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
- NIMH NIH HHS
- NIDA NIH HHS
Zitieren
APA
Rosenberg, E. C., Chamberland, S., Bazelot, M., Nebet, E. R., Wang, X., McKenzie, S., Jain, S., Greenhill, S., Wilson, M., Marley, N., Salah, A., Bailey, S., Patra, P. H., Rose, R., Chenouard, N., Sun, S. E. D., Jones, D., Buzsáki, G., Devinsky, O., …, & Tsien, R. W. (2023). Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity. Neuron, 111(8), 1282-1300.e8. https://doi.org/10.1016/j.neuron.2023.01.018
Vancouver
Rosenberg EC, Chamberland S, Bazelot M, Nebet ER, Wang X, McKenzie S, et al. Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity. Neuron. 2023;111(8):1282-1300.e8. doi:10.1016/j.neuron.2023.01.018
BibTeX
@article{Rosenberg2023,
author = {Rosenberg, Evan C and Chamberland, Simon and Bazelot, Michael and Nebet, Erica R and Wang, Xiaohan and McKenzie, Sam and Jain, Swati and Greenhill, Stuart and Wilson, Max and Marley, Nicole and Salah, Alejandro and Bailey, Shanice and Patra, Pabitra Hriday and Rose, Rebecca and Chenouard, Nicolas and Sun, Simón E D and Jones, Drew and Buzsáki, György and Devinsky, Orrin and Woodhall, Gavin and Scharfman, Helen E and Whalley, Benjamin J and Tsien, Richard W},
title = {Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity},
journal = {Neuron},
year = {2023},
volume = {111},
number = {8},
pages = {1282--1300.e8},
doi = {10.1016/j.neuron.2023.01.018}
}
EUVIMED